Skip to Content

Join the 'Leucovorin' group to help and get support from people like you.

Leucovorin News

Elderly With Advanced Colon Cancer Often Get Costly, Dubious Treatments: Study

Posted 10 Mar 2016 by

THURSDAY, March 10, 2016 – Expensive drugs are being given far more often to elderly patients with advanced colon cancer, but they offer almost no benefit, a new study suggests. "This research found that there is a trend for elderly late-stage colorectal cancer patients to receive newer, more expensive drugs," said lead author Cathy Bradley, associate director for population science research at ...

Cheaper Alternative to Turing's Pricey Daraprim Soon Available

Posted 1 Dec 2015 by

A low-cost alternative to the infection-fighting drug Daraprim will be available to patients as soon as next week. The price of Daraprim rose 5,000 percent after it was acquired by Turing Pharmaceuticals earlier this year. The drug is used to treat a parasitic infection called toxoplasmosis. On Tuesday, Imprimis Pharmaceuticals announced it found a backer to distribute a $1-per-pill alternative ...

FDA Medwatch Alert: Leucovorin Calcium Injection (Bedford Laboratories): Recall - Visible Particulate Matter

Posted 10 Jul 2012 by

  [Posted 07/06/2012] ISSUE: Bedford Laboratories issued a nationwide recall of three lots of Leucovorin Calcium Injection, due to the discovery of visible crystalline particulate matter in a small number of vials. To date, there have been no reports of any adverse events for the lots being recalled. The particulate matter has been identified as active drug substance and not foreign material or ...

Chemo Combo May Help Stave Off Pancreatic Cancer Death

Posted 11 May 2011 by

WEDNESDAY, May 11 – A four-drug chemotherapy regimen for deadly pancreatic cancer nearly doubled patients' survival time compared to standard chemotherapy, a new study suggests. In late-stage trials, French researchers split a group of 342 patients with advanced pancreatic adenocarcinoma, the most common form of the disease, into two groups. Half received gemcitabine, the standard treatment, ...

FDA Approves Fusilev for Use in Patients with Colorectal Cancer

Posted 2 May 2011 by

IRVINE, Calif.--(BUSINESS WIRE)--Apr 30, 2011 - Spectrum Pharmaceuticals a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, received approval from the U.S. Food and Drug Administration (FDA) on April 29, 2011, for the use of Fusilev (levoleucovorin) in combination with 5-fluorouracil in the palliative treatment of patients ...

Ask a Question

Further Information

Related Condition Support Groups

Methotrexate Overdosage, Colorectal Cancer, Folic Acid Antagonist Overdose, Anemia, Megaloblastic, Methotrexate Rescue, Pneumocystis Pneumonia, Pneumocystis Pneumonia Prophylaxis, Toxoplasmosis, Toxoplasmosis - Prophylaxis

Related Drug Support Groups


Leucovorin Patient Information at